Bloodplasma and viral safety

[Frank Lafort]

SYMPOSIUM QUALITY AND SAFETY OF PLASMA PRODUCTS
Thursday, 19 October 1995, Brussels (Belgium)

The  European Plasma Fractionation Association (EPFA) and The European Association of the Plasma Product Industry (EAPPI) and the
are pleased to present  the: 2nd Annual European Regulatory Affairs Symposium 
"Quality and Safety of Plasma Products" (http://www.cyber.nl/epfa/
 
The Symposium (Brussels 19 october 1995) is intended to bring together the private 
and public sectors of the Plasma Products Industry, the European Union and 
Member State government officials to participate in presentations and 
discussions on a range of public policy  and regulatory topics related to plasma for further 
manufacture, and the quality and  safety of plasma products. Specifically, the Symposium 
will address: 
1) Benefits of a structured dialogue between the regulatory authorities 
and manufacturers of plasma products;
2) Regulatory developments related to source material issues; 
3) Plasma products and manufacturing issues including 
    viral safety and pre- and  post-licensing issues; 

The EAPPI represents twelve of the largest commercial 
manufacturers of plasma  products in Europe. EPFA represents the 
not-for-profit manufacturers of  plasma products in Europe and abroad.
The Symposium will provide an overview of the regulatory 
framework for many  critical aspects of the collection of blood and plasma 
and the manufacture,  regulation, control and oversight of plasma 
products. 

 Via  http://www.cyber.nl/epfa/  speeches of the 
speakers are going to be published and ( new) information
 about EPFA and its members. .

Speakers include:
Dr. A.J. Croockewit, university hospital Nijmegen ( The Netherlands)
Dr. C. Gardi, Zentrallaboratorium Blutspendedienst SRK ( Switzerland) 
Dr. D.B. McClelland, Scottish National Blood Transfusion Service (UK)     
Dr. Philip Minor, the National Institute for Biological Standards and 
Control (UK)                                                 
 Mr. Philip Meyer, EC DG III (Belgium)      
Ms Karen Lipton , American Association of Blood Banks (USA)
Prof. Dr. U. Diekamp, DRK Plasmaverarbeitungsgesellschaft (BRD)
Mr. Peter Castle, European Pharmacopoeia (France)
Dr. J.C. Fratantoni, Center for Biologics, Evaluation and Research, 
FDA (USA)
Mr. Jon Betts, Alpha Therapeutic UK Ltd
Dr. Clive H. Dash, Bio Products Laboratory (UK)
Dr. J. Hilfenhaus, Behringwerke A.G. (BRD)
Mr. Eduardo Pisani, Immuno SA-NV (Belgium)
Mr. Richard Walker, Bio Products Laboratory (UK)
Mr. Knut Hansen, president EAPPI (Belgium)
Prof. Dr. W.G. van Aken, president EPFA (The Netherlands)

For further information:

 Mr. Theo Evers,  Executive Director (EPFA) 
E-mail address: T.Evers at epfa.nl
Telephone: +31.20.512.35.61
Telefax:      +31.20.512.35.59